Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;6(2):153-9.
doi: 10.2217/fmb.10.166.

Human coronavirus NL63: a clinically important virus?

Burtram C Fielding  1
Affiliations

Human coronavirus NL63: a clinically important virus?

Burtram C Fielding. Future Microbiol. 2011 Feb.

Abstract

Respiratory tract infection is a leading cause of morbidity and mortality worldwide, especially among young children. Human coronaviruses (HCoVs) have only recently been shown to cause both lower and upper respiratory tract infections. To date, five coronaviruses (HCoV-229E, HCoV-OC43, SARS-CoV, HCoV-NL63 and HCoV HKU-1) that infect humans have been identified, four of which (HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU-1) circulate continuously in the human population. Human coronavirus NL63 (HCoV-NL63) was first isolated from the aspirate from a 7-month-old baby in early 2004. Infection with HCoV-NL63 has since been shown to be a common worldwide occurrence and has been associated with many clinical symptoms and diagnoses, including severe lower respiratory tract infection, croup and bronchiolitis. HCoV-NL63 causes disease in children, the elderly and the immunocompromised, and has been detected in 1.0-9.3% of respiratory tract infections in children. In this article, the current knowledge of human coronavirus HCoV-NL63, with special reference to the clinical features, prevalence and seasonal incidence, and coinfection with other respiratory viruses, will be discussed.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The author receives funding from the National Research Foundation (South Africa) and the University of the Western Cape Senate Research Fund. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

References

    1. Sloots TP, Whiley DM, Lambert SB, Nissen MD: Emerging respiratory agents: new viruses for old diseases? J. Clin. Virol. 42(3) 233–243 (2008). - PMC - PubMed
    1. Li H, McCormac MA, Estes RW et al.: Simultaneous detection and high-throughput identification of a panel of R NA viruses causing respiratory tract infections. J. Clin. Microbiol. 45(7) 2105–2109 (2007). - PMC - PubMed
    1. Ren L, Gonzalez R, Wang Z et al.: Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005–2007. Clin. Microbiol. Infect. 15(12) 1146–1153 (2009). - PMC - PubMed
    1. Schuster A: Respiratory tract infections and lung function in early life – ‘Cling together, swing together’. Allergol. Immunopathol. (Madr.) 38(3) 107–109 (2010). - PubMed
    1. van der Hoek L, Ihorst G, Sure K et al.: Burden of disease due to human coronavirus NL63 infections and periodicity of infection. J. Clin. Virol. 48(2) 104–108 (2010). - PMC - PubMed

    2. ▪▪ Estimates the burden of disease due to NL63 infections using a population-based study of children under 3 years of age with lower respiratory tract infection. Also shows NL63 infections follow a 2-year interepidemic period with peaks in winter.

MeSH terms